Supplementary Table S1 from MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table S1 compares the intestinal tumor counts and percent of tumors progressing to cancer for mouse models with activating alterations in PIK3CA.
Authors: Stephanie L. Fricke, Susan N. Payne, Peter F. Favreau, Jeremy D. Kratz, Cheri A. Pasch, Tyler M. Foley, Alexander E. Yueh, Dana R. Van De Hey, Mitchell G. Depke, Demetra P. Korkos, Gioia Chengcheng Sha, Rebecca A. DeStefanis, Linda Clipson, Mark E. Burkard, Kayla K. Lemmon, Benjamin M. Parsons, Paraic A. Kenny, Kristina A. Matkowskyj, Michael A. Newton, Melissa C. Skala, Dustin A. Deming
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362485052